Blueprint Medicines (BPMC) PT Raised to $92 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $92.29 --0%
Rating Summary:
18 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Rating Summary:
18 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $92.00 (from $88.00) while maintaining a Overweight rating.
You May Also Be Interested In
- PVR Inox Ltd (PVRINOX:IN) PT Lowered to INR1,870 at HSBC
- Western New England Bancorp (WNEB) PT Lowered to $7.50 at Piper Sandler
- Atlantic Union Bankshares (AUB) PT Lowered to $35 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
